<Li> Phase II awards grants of "up to $1 million, for as many as 2 years," in order to facilitate expansion of Phase I results . Research and development work is performed and the developer evaluates the potential for commercialization . Up to 2014 Phase II grants were awarded exclusively to Phase I award winners but in 2014 the DOD, NIH and Education are allowed to make "direct to Phase II" awards; NIH and DARPA (part of DOD) had active solicitations for this in the Summer of 2014 . </Li> <Li> Phase III is intended to be the time when innovation moves from the laboratory into the marketplace . No additional SBIR set - aside funds may be awarded for Phase III . "The small business must find funding in the private sector or other non-SBIR federal agency funding ." </Li> <P> The company owns the intellectual property and all commercialization rights . Companies such as Symantec, Qualcomm, Da Vinci Surgical System, Jawbone, Lift Labs, Natel Energy and iRobot received critically important early - stage funding from this program . </P> <P> Each Federal agency with an extramural budget for R&D in excess of $100,000,000 must participate in the SBIR Program and reserve at least 3.2% of such budget in fiscal year 2017 and each fiscal year after . A Federal agency may exceed these minimum percentages . In 2010, the SBIR program across 11 federal agencies provided over $2 Billion in grants and contracts to small U.S. businesses for research in innovation leading to commercialization . </P>

Small business innovation research (sbir) grants